文献速递重症综合管理与镇静镇痛

重症监护相关的出院后6个月生活质量与自主性丧失:COVID-19真的使其更糟吗

Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?
PubMed 文献 · Crit Care · 2022-04-04
一句话结论老年ICU患者出院后6个月,COVID-19相关ICU住院与非COVID-19相关ICU住院相比,生活质量或自主性并未更低。

该研究比较了两个前瞻性多中心队列中入住ICU的老年患者:Senior-COVID-Rea队列(年龄>60岁、确诊COVID-19)与FRAGIREA队列(年龄>70岁),纳入在入院后第180天评估了ADL评分和生活质量的患者,共93例COVID-19患者和185例对照ICU患者。两组在年龄、体重指数、机械通气、ICU住院时间以及ADL和SAPS II评分上不平衡。采用有序logistic回归调整这些因素后,COVID-19患者发生日常活动丧失(aOR 0.47 [95%CI 0.23;0.94])、活动能力丧失(aOR 0.30 [95%CI 0.14;0.63])和ADL评分丧失(aOR 0.30 [95%CI 0.14;0.63])的可能性更低。第180天时,52例(56%)COVID-19患者有呼吸困难体征,37例(40%)仍使用镇痛药,17例(18%)使用抗焦虑药,14例(13%)使用抗抑郁药。结论认为COVID-19相关ICU住院与非COVID-19相关ICU住院相比,并未与更低的生活质量或自主性相关。

要点

  • 调整年龄、BMI、机械通气、ICU住院时间、ADL和SAPS II后,COVID-19患者日常活动丧失可能性更低(aOR 0.47 [95%CI 0.23;0.94])。
  • COVID-19患者活动能力丧失可能性更低(aOR 0.30 [95%CI 0.14;0.63]),ADL评分丧失可能性也更低(aOR 0.30 [95%CI 0.14;0.63])。
  • 第180天时,52例(56%)COVID-19患者有呼吸困难体征,37例(40%)仍使用镇痛药。
  • 第180天时,17例(18%)COVID-19患者使用抗焦虑药,14例(13%)使用抗抑郁药。
  • 两组在年龄、BMI、机械通气、ICU住院时间、ADL和SAPS II评分上不平衡,结果经有序logistic回归调整。

适用人群与场景

  • COVID-19组:Senior-COVID-Rea队列中确诊COVID-19、入住ICU、年龄超过60岁的患者。
  • 对照组:FRAGIREA队列中入住ICU、年龄超过70岁的非COVID-19相关原因患者。
  • 纳入两队列中在入院后第180天完成ADL评分和生活质量评估的患者。

研究设计与关键结果

  • 研究设计:两个前瞻性多中心研究的比较,纳入93例COVID-19患者和185例对照ICU患者。
  • 两组在年龄、体重指数、机械通气、ICU住院时间以及ADL和SAPS II评分上不平衡。
  • 采用有序logistic回归调整上述因素后,COVID-19患者日常活动丧失可能性更低(aOR 0.47 [95%CI 0.23;0.94])。
  • 调整后COVID-19患者活动能力丧失可能性更低(aOR 0.30 [95%CI 0.14;0.63])。
  • 调整后COVID-19患者ADL评分丧失可能性更低(aOR 0.30 [95%CI 0.14;0.63])。
  • 第180天时,52例(56%)COVID-19患者有呼吸困难体征,37例(40%)仍使用镇痛药,17例(18%)使用抗焦虑药,14例(13%)使用抗抑郁药。

证据类型、等级与局限

  • 证据类型:两个前瞻性多中心研究的比较。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为COVID-19相关ICU住院与非COVID-19相关ICU住院相比,并未与更低的生活质量或自主性相关。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare old patients hospitalized in ICU for respiratory distress due to COVID-19 with old patients hospitalized in ICU for a non-COVID-19-related reason in terms of autonomy and quality of life.

DESIGN: Comparison of two prospective multi-centric studies.

SETTING: This study was based on two prospective multi-centric studies, the Senior-COVID-Rea cohort (COVID-19-diagnosed ICU-admitted patients aged over 60) and the FRAGIREA cohort (ICU-admitted patients aged over 70).

PATIENTS: We included herein the patients from both cohorts who had been evaluated at day 180 after admission (ADL score and quality of life).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 93 COVID-19 patients and 185 control-ICU patients were included. Both groups were not balanced on age, body mass index, mechanical ventilation, length of ICU stay, and ADL and SAPS II scores. We modeled with ordered logistic regression the influence of COVID-19 on the quality of life and the ADL score. After adjustment on these factors, we observed COVID-19 patients were less likely to have a loss of usual activities (aOR [95% CI] 0.47 [0.23; 0.94]), a loss of mobility (aOR [95% CI] 0.30 [0.14; 0.63]), and a loss of ADL score (aOR [95% CI] 0.30 [0.14; 0.63]). On day 180, 52 (56%) COVID-19 patients presented signs of dyspnea, 37 (40%) still used analgesics, 17 (18%) used anxiolytics, and 14 (13%) used antidepressant.

CONCLUSIONS: COVID-19-related ICU stay was not associated with a lower quality of life or lower autonomy compared to non-COVID-19-related ICU stay.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Thiolliere F, Falandry C, Allaouchiche B, et al. Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse? Crit Care. 2022. PMID: 35379312. doi:10.1186/s13054-022-03958-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。